GMP Analysis for Biopol Chemicals
Generated: 2026-02-07T19:03:49.129570
================================================================================

STRUCTURED DATA:
  GMP Price: ₹0
  GMP %: None%
  Issue Price: ₹None
  Expected Listing: ₹None
  IPO Status: None

================================================================================

COMPREHENSIVE ANALYSIS:
**Comprehensive GMP Analysis for Biopol Chemicals IPO**

### 1. Current GMP Status
- **Current GMP Price and Percentage:** The current GMP (Grey Market Premium) for Biopol Chemicals is ₹- (no data available), indicating no premium or discount in the grey market as of the latest update.
- **Issue Price and Expected Listing Price:** The issue price is fixed at ₹102 to ₹108 per share. Without a current GMP, the expected listing price cannot be accurately determined.
- **GMP Sentiment:** Given the lack of GMP data, the sentiment cannot be classified as positive, negative, or neutral.

### 2. Market Sentiment Analysis
- **Market Demand Indication:** The absence of GMP data makes it challenging to assess market demand accurately. However, the IPO's subscription status can provide insights into investor interest.
- **Oversubscription Status:** As of the first day, the IPO saw an overall subscription of nearly 40%, with the retail portion booked at 36%, and the segment reserved for NIIs subscribed to 4%. This indicates a moderate level of interest.
- **Investor Confidence:** The initial subscription numbers suggest cautious optimism among investors, but the lack of GMP data limits the ability to gauge confidence levels accurately.

### 3. Listing Gain Potential
- **Expected Listing Gains:** Without current GMP, expected listing gains cannot be estimated.
- **Risk-Reward Assessment:** The risk-reward assessment is challenging due to the absence of GMP data. Investors should consider the company's financials, industry trends, and market conditions.
- **Comparison with Similar IPOs:** No comparable IPOs are mentioned in the context for a direct comparison.

### 4. IPO Timeline & Status
- **Current IPO Status:** The IPO opened for public subscription on February 6, 2026, and is scheduled to close on February 10, 2026.
- **Important Dates:**
  - Opening Date: February 6, 2026
  - Closing Date: February 10, 2026
  - Listing Date: February 13, 2026
- **Time-Sensitive Insights:** Investors should monitor the subscription status and any updates on GMP closely to make informed decisions.

### 5. Investment Recommendation
- **Application Recommendation:** The decision to apply for this IPO should be based on the company's fundamentals, industry outlook, and personal investment goals. The absence of GMP data limits the ability to provide a recommendation based on grey market trends.
- **Grey Market Trends:** Not available due to the lack of GMP data.
- **Risk Factors:** Investors should consider the company's business model, financial performance, and market conditions before making a decision.

### 6. Key Takeaways
- **Insufficient GMP Data:** The analysis is limited by the absence of current GMP data, making it challenging to assess market sentiment and potential listing gains accurately.
- **Moderate Subscription:** The IPO saw a moderate level of subscription on its first day, indicating some interest from investors.
- **Fundamental Analysis:** Investors should focus on the company's financial performance, industry trends, and growth potential to make an informed decision.
- **Market Conditions:** Keep an eye on overall market conditions and any updates from the company that could impact the IPO's performance.
- **Listing and Beyond:** The actual listing price and the company's performance post-listing will provide clearer insights into the investment's potential.

Given the information available, potential investors should prioritize a thorough review of Biopol Chemicals' financials, industry position, and growth prospects to guide their investment decision.

================================================================================
Sources: 3 websites scraped
  1. https://ipowatch.in/biopol-chemicals-ipo-gmp-grey-market-premium/
  2. https://www.livemint.com/market/ipo/biopol-chemicals-ipo-day-1-gmp-subscription-status-price-other-key-details-of-sme-ipo-in-10-points-11770358373752.html
  3. https://firstock.in/blog/fractal-analytics-ipo-gmp-2026/
